The role of positron emission tomography in occult primary head and neck cancers

Cancer Journal from Scientific American

Volumn 5, Issue 4, 1999, Pages 214-218

  Safa, Afshin A ^a,c   Tran, Luu M ^b   Rege, Sheila ^a   Brown, Charles V ^b   Mandelkern, Mark A ^b   Wang, Marilene B ^b   Sadeghi, Ahmed ^b   Juillard, Guy ^a  

^a UNIVERSITY OF CALIFORNIA   (United States)

^b VETERANS AFFAIRS MEDICAL CENTER   (United States)

^c Dept of Nucl Med and Biophysics W Los Angeles Vet Admin Hospital ^*  (United States)

Author keywords

Diagnosis; Emission CT; Flourine radioisotope; Head and neck neoplasms; Tomography

Indexed keywords

FLUORODEOXYGLUCOSE;

ADULT; AGED; ARTICLE; CANCER SCINTISCANNING; CERVICAL LYMPH NODE; CLINICAL ARTICLE; CONTRAST ENHANCEMENT; DIAGNOSTIC ACCURACY; DIAGNOSTIC VALUE; HEAD AND NECK CANCER; HUMAN; LYMPH NODE BIOPSY; LYMPH NODE METASTASIS; MALE; POSITRON EMISSION TOMOGRAPHY; PRIORITY JOURNAL; SQUAMOUS CELL CARCINOMA;

EID: 0032748350     PISSN: 10814442     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (17)

1. Million RR, Cassissi NJ, Mancuso AA. The unknown primary. In: Million RR, Cassissi NJ, eds. Management of Head and Neck Cancer: A Multidisciplinary Approach. (2nd ed). Philadelphia: JB Lippincott, 1994:311-321.
2. Carlson LS, Fletcher GH, Oswald MJ. Guidelines for radiotherapeutic techniques for cervical metastases from an unknown primary. Int J Radiat Oncol Biol Phys 1986;12:2101-2110.
3. Reddy SP, Marks JE. Metastatic carcinoma in the cervical lymph nodes from an unknown primary site: results of bilateral neck plus mucosal irradiation vs. ipsilateral neck irradiation. Int J Radiat. Oncol Biol Phys 1997;37:797-802.
4. Sinnathamby K, Peters LJ, Laidlaw C et al. The occult head and neck primary: to treat or not to treat? Clin Oncol 1997;9:322-329.
5. Muraki AS, Mancuso AA, Harnsberger HR. Metastatic cervical adenopathy from tumors of unknown origin: the role of CT. Radiology 1984;152:749-753.
6. Reske SN, Bares R, Bull U et al. Clinical value of positron emission tomography (PET) in oncologic questions: results of an interdisciplinary consensus conference. Schirmerreschaft der Deutschen Gesellschaft for Nuklearmedizin. Nuklearmedizin 1996;35:42-52.
7. Greven KM, Williams DW 3rd, Keyes JW Jr et al. Positron emission tomography of patients with head and neck carcinoma before and after high dose irradiation. Cancer 1994;74:1355-1359.
8. Rege S, Maass A, Chaiken L et al. Use of positron emission tomography with fluorodeoxyglucose in patients with extracranial head and neck cancers. Cancer 1994;73:3047-3058.
9. Schipper JH, Schrader M, Arweiler D et al. Positron emission tomography for primary tumor detection in lymph node metastases with unknown primary tumor. HNO 1996;44:254-257.
10. Braams JW, Pruim J, Kole AC et al. Detection of unknown primary head and neck tumors by positron emission tomography. Int J Oral Maxillofac Surg 1997;26:112-115.
11. Mukherji SK, Drane WE, Mancuso AA et al. Occult primary tumors of the head and neck: detection with 2-[F-18]fluoro-2deoxy-D-glucose SPECT. Radiology 1996;199:761-766.
12. Keyes JW Jr, Watson NE Jr, Williams DW 3rd et al. FDG PET in head and neck cancer. AJR Am J Roentgenol 1997;169:1663-1669.
13. Hillsamer PJ, Schuller DE, McGhee RB et al. Improving diagnostic accuracy of cervical metastases with computed tomography and magnetic resonance imaging. Arch Otolaryngol Head Neck Surg 1990;116:1297-1301.
14. Hawkins RA, Hoh C, Dahlbom M et al. PET cancer evaluation with FDG. J Nucl Med 1991;32:1555-1558.
15. Rege S, Chaiken L, Hoh C et al. Quantitation of radiotherapy induced changes in FDG uptake in normal and malignant structures. Radiology 1993;189:807-812.
16. Imran M, Kubota K, Yamada S et al. Lesion to background ratio in nonattenuation corrected whole-body FDG-PET images. J Nucl Med 1997;39:1219-1223.
17. Vansteenkiste J, Stroobants S, DeLeyn P et al. Lymph node staging in non-small-cell lung cancer with FDG-PET scan: a prospective study on 690 lymph node stations from 68 patients. J Clin Oncol 1998;16:2142-2149.